OCD is a condition which causes intrusive and recurring obsessions and/or compulsions that interfere with a person’s daily activities and quality of life. Over 2 million adults in the United States are diagnosed with OCD each year. Conventional OCD treatments are only effective in about 50% of cases.
Dr. Geoffrey Grammer, Chief Medical Officer of the Company stated that: “the launch of this OCD treatment demonstrates our commitment to utilizing the latest developments in Transcranial Magnetic Stimulation to offer our patients the very best care possible. The H7 coil system developed by Brainsway provides us the new capability to treat areas of the brain involved in OCD and provide patients a truly novel approach to symptom relief.”
If Covid-19 and social isolation are heightening your symptoms of depression, Greenbrook TMS therapy may be able to help. At Greenbrook, we specialize in TMS therapy — an FDA-cleared, non-invasive treatment for treatment-resistant depression and OCD without harmful side effects. See if TMS therapy is right for you by clicking here to take a brief assessment: